We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$882M
AUM Growth
+$126M
Cap. Flow
+$66.7M
Cap. Flow %
7.55%
Top 10 Hldgs %
34.21%
Holding
2,922
New
175
Increased
1,422
Reduced
927
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Healthcare 8%
3 Financials 7.49%
4 Consumer Staples 6.68%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIB icon
1351
Grupo Cibest SA
CIB
$21.1B
$37.1K ﹤0.01%
1,299
-551
-30% -$14.2K
TSEM icon
1352
Tower Semiconductor
TSEM
$23.2B
$37.1K ﹤0.01%
858
+494
+136% +$21.5K
PAA icon
1353
Plains All American Pipeline
PAA
$17.1B
$37K ﹤0.01%
3,145
+61
+2% +$723
MTUS icon
1354
Metallus
MTUS
$885M
$36.9K ﹤0.01%
2,032
-191
-9% -$3.39K
HAS icon
1355
Hasbro
HAS
$13.4B
$36.9K ﹤0.01%
605
+97
+19% +$6.06K
ATKR icon
1356
Atkore
ATKR
$2.59B
$36.9K ﹤0.01%
325
-10
-3% -$1.05K
UGP icon
1357
Ultrapar
UGP
$6.77B
$36.8K ﹤0.01%
15,221
+11,830
+349% +$29.6K
BUSE icon
1358
First Busey Corp
BUSE
$2.57B
$36.8K ﹤0.01%
1,490
-771
-34% -$19.3K
INVX
1359
Innovex International
INVX
$1.8B
$36.8K ﹤0.01%
1,355
+1,030
+317% +$24.5K
LTC
1360
LTC Properties
LTC
$2.14B
$36.7K ﹤0.01%
1,034
-13
-1% -$495
PCRX icon
1361
Pacira BioSciences
PCRX
$1.06B
$36.6K ﹤0.01%
949
+74
+8% +$3.6K
SAIC icon
1362
Saic
SAIC
$5.18B
$36.6K ﹤0.01%
330
-11
-3% -$1.16K
RSP icon
1363
Invesco S&P 500 Equal Weight ETF
RSP
$98.3B
$36.5K ﹤0.01%
258
-62
-19% -$8.67K
ELME
1364
Elme Communities
ELME
$143M
$36.2K ﹤0.01%
2,034
-2,275
-53% -$41.9K
JBGS
1365
JBG SMITH
JBGS
$839M
$36.1K ﹤0.01%
1,903
+554
+41% +$10.7K
IRWD icon
1366
Ironwood Pharmaceuticals
IRWD
$626M
$36K ﹤0.01%
2,902
-866
-23% -$9.82K
VRE
1367
DELISTED
Veris Residential
VRE
$35.9K ﹤0.01%
2,256
+1,113
+97% +$16.4K
HOMB icon
1368
Home BancShares
HOMB
$6.29B
$35.9K ﹤0.01%
1,576
+1,121
+246% +$27.2K
INVA icon
1369
Innoviva
INVA
$1.6B
$35.9K ﹤0.01%
2,708
+543
+25% +$7.14K
XLV icon
1370
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
$35.9K ﹤0.01%
264
-36
-12% -$4.77K
NTRA icon
1371
Natera
NTRA
$36.8B
$35.8K ﹤0.01%
892
-131
-13% -$5.4K
OMF icon
1372
OneMain Financial
OMF
$7.17B
$35.7K ﹤0.01%
1,072
-240
-18% -$8.51K
OII icon
1373
Oceaneering
OII
$4.83B
$35.5K ﹤0.01%
2,030
+1,237
+156% +$16.4K
BYD icon
1374
Boyd Gaming
BYD
$6.69B
$35.5K ﹤0.01%
651
-123
-16% -$6.93K
YELP icon
1375
Yelp
YELP
$1.51B
$35.4K ﹤0.01%
1,293
-1,323
-51% -$42K

Similar funds

Quadrant Capital Group's Q4 2022 Portfolio in Review

As of Q4 2022, Quadrant Capital Group held 2,922 positions worth $882M, up 17% from $756M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group deployed $66.7M of net new capital in Q4 2022, opening 175 new positions and adding to 1,422 existing holdings. Its largest new stake was Vanguard International High Dividend Yield ETF: 6,252 shares worth $372K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $7.2M trimmed.

  • Quadrant Capital Group's largest Q4 2022 buy was Vanguard International High Dividend Yield ETF: 6,252 shares worth $372K.
  • Quadrant Capital Group added most to Vanguard Short-Term Bond ETF in Q4 2022, an estimated $25.7M increase.
  • Quadrant Capital Group's biggest Q4 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $7.2M.
  • Quadrant Capital Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $393K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $882M portfolio in Q4 2022.
  • Quadrant Capital Group opened 175 new positions and closed 190 in Q4 2022.
  • Quadrant Capital Group's portfolio value rose 17% quarter-over-quarter to $882M.

Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.